Wall Street Zen Upgrades Lumexa Imaging (NASDAQ:LMRI) to “Buy”

Lumexa Imaging (NASDAQ:LMRI) was upgraded by research analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a report released on Saturday.

A number of other equities research analysts have also recently issued reports on LMRI. Weiss Ratings raised shares of Lumexa Imaging from a “sell (e)” rating to a “sell (d)” rating in a research note on Thursday. Barclays lowered their price target on shares of Lumexa Imaging from $15.00 to $9.00 and set an “overweight” rating for the company in a research note on Wednesday, May 20th. One analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $16.00.

Lumexa Imaging Trading Up 14.4%

Shares of NASDAQ LMRI opened at $12.10 on Friday. Lumexa Imaging has a one year low of $6.45 and a one year high of $19.45. The company’s 50 day simple moving average is $8.93.

Insider Buying and Selling

In related news, Director Brett Brodnax acquired 35,000 shares of the stock in a transaction on Tuesday, May 19th. The stock was purchased at an average price of $7.25 per share, for a total transaction of $253,750.00. Following the completion of the transaction, the director owned 62,027 shares of the company’s stock, valued at $449,695.75. This trade represents a 129.50% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.70% of the stock is owned by company insiders.

Institutional Investors Weigh In On Lumexa Imaging

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in LMRI. T. Rowe Price Investment Management Inc. purchased a new position in shares of Lumexa Imaging in the fourth quarter valued at about $37,139,000. Janus Henderson Group PLC purchased a new stake in shares of Lumexa Imaging during the fourth quarter worth about $36,860,000. ArrowMark Colorado Holdings LLC bought a new stake in shares of Lumexa Imaging in the fourth quarter worth about $27,750,000. Healthcare of Ontario Pension Plan Trust Fund bought a new stake in shares of Lumexa Imaging in the fourth quarter worth about $27,750,000. Finally, Invesco Ltd. purchased a new position in Lumexa Imaging during the 4th quarter valued at about $26,562,000.

About Lumexa Imaging

We are one of the largest national providers of diagnostic imaging services(1). Our platform is integrated, scalable and has a proven track record of creating value for our stakeholders. As of September 30, 2025, we and our affiliates operated the second largest(1) outpatient imaging center footprint in the United States. It spans 184 centers(2)across 13 states and includes eight joint venture partnerships with health systems. Our centers are in attractive metropolitan statistical areas (“MSAs”).